Samsung won FDA nod for a Remicade biosim, Otsuka expanded anemia deal with Akebia, analysts are cautiously optimistic about China's foreign drug proposal.
The Bill & Melinda Gates Foundation shelled out $12 million on a low-cost inactivated polio vaccine manufacturing platform as supplies to international procurement run 50% behind expectations.
